Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 278 No 7444 p331
24 March 2007

This article
Reprint   Photocopy

  Acrobat Reader


News summary


National framework for pandemic flu published

How to comment on the pandemic flu guidance

The UK guidance is available. Comments can be sent to pandemicflu@dh.gsi.gov.uk or to The National Flu Pandemic Preparedness Team, Department of Health, 452C Skipton House, 80 London Road, London SE1 6LH.

The Scottish framework is available and comments can be sent to pandemicflu@scotland.gsi.gov.uk or to The Pandemic Flu Co-ordination Team, Health Department, Scottish Executive, 3E.S. St Andrew’s House, Regent Road, Edinburgh EH1 3DG.

Comments should be received by 16 May 2007

During an influenza pandemic, pharmacists will have a critical role in ensuring an effective community-based response, minimising disruption and maintaining essential services, according to draft guidance published by the Department of Health.

Primary care professionals, including GPs, pharmacists, community nurses and supporting service providers, should participate actively in the development of plans for local health services, and all NHS organisations and contractors should ensure they have continuity plans in place, it says.

The guidance indicates that the Department of Health is working on proposals to widen the groups of staff who are able to prescribe and dispense medicines during a pandemic and says that further guidance will be issued in due course. It adds that the DoH also plans to make regulatory provision for alternative prescription and supply arrangements during a pandemic.

The guidance includes a national framework, which is intended to replace previous plans issued by UK health departments, plus several supporting documents, including an ethical framework, guidance on provision of health care in the community setting in England as well as guidance for acute hospitals, adult social care and ambulance services. Although the national framework provides for a consistent UK-wide approach, some differences in operational arrangements apply in the devolved administrations. The Scottish Executive Health Department has published its own draft framework based on the UK guidance. Wales is following the UK guidance.

The national framework indicates that most influenza sufferers will be assessed and treated in the community. It explains that a national flu hotline number will be publicised through which people will be assessed and, if found to be symptomatic, given a reference number and asked to send a representative to collect antiviral medication from a designated distribution centre.

The English guidance for providing health care in a community setting states that, within 24 hours of a UK alert level 2 being announced (sporadic cases in the UK), each primary care trust will receive an initial allocation of two weeks’ supply of oseltamivir based on its resident population numbers and assuming a 25 per cent clinical attack rate. Storage, onward cascade to distribution points and subsequent distribution arrangements should address the need to protect stock and staff, and be made in consultation with the police and local pharmacy advisers, it says.

In Scotland, limited amounts of the national stockpile are currently predistributed to local health boards (5 per cent to mainland boards and 10 per cent to the islands). Main stock will not be made available until UK alert level 2 is announced.

Pharmacies should consider how they will minimise the potential for their premises to spread the virus, including the availability of handwashing facilities, tissue disposal and reducing the risk of droplet spread in seated areas.

The national framework also recommends that PCTs start to identify and sign up volunteers, such as health professionals who have recently retired or are on a career break, to provide support in the event of a pandemic.

The Royal Pharmaceutical Society, the Pharmaceutical Services Negotiating Committee and Community Pharmacy Wales, have published joint guidance for community pharmacists on service continuity planning (PDF 160K).

Back to Top


©The Pharmaceutical Journal